Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
Year: 2012
Type: article
Abstract: Since the separation of Pseudallescheria boydii and P. apiosperma in 2010, limited data on species-specific susceptibility patterns of these and other species of Pseudallescheria and its anamorph Scedosporium have been reported. This study presents the antifungal susceptibility patterns of members affiliated with both entities. Clinical and environmental isolates (n = 332) from a wide range of sources and origins were identified down to species level and tested according to CLSI M38-A2 against eight antifungal compounds. Whereas P. apiosperma (geometric mean MIC/minimal effective concentration [MEC] values of 0.9, 2.4, 7.4, 16.2, 0.2, 0.8, 1.5, and 6.8 μg/ml for voriconazole, posaconazole, isavuconazole, itraconazole, micafungin, anidulafungin, caspofungin, and amphotericin B, respectively) and P. boydii (geometric mean MIC/MEC values of 0.7, 1.3, 5.7, 13.8, 0.5, 1.4, 2.3, and 11.8 μg/ml for voriconazole, posaconazole, isavuconazole, itraconazole, micafungin, anidulafungin, caspofungin, and amphotericin B, respectively) had similar susceptibility patterns, those for S. aurantiacum, S. prolificans, and S. dehoogii were different from each other. Voriconazole was the only drug with significant activity against S. aurantiacum isolates. The MIC distributions of all drugs except voriconazole did not show a normal distribution and often showed two subpopulations, making a species-based prediction of antifungal susceptibility difficult. Therefore, antifungal susceptibility testing of all clinical isolates remains essential for targeted antifungal therapy. Voriconazole was the only compound with low MIC values (MIC(90) of ≤ 2 μg/ml) for P. apiosperma and P. boydii. Micafungin and posaconazole showed moderate activity against the majority of Scedosporium strains.
DOI: 10.1128/aac.05910-11
Institutions: Federal Institute for Drugs and Medical Devices, Innsbruck Medical University, Universität Innsbruck, Westerdijk Fungal Biodiversity Institute, University of Amsterdam, Radboud University Nijmegen, Radboud University Medical Center, Mashhad University of Medical Sciences, Ghaem Hospital, Canisius-Wilhelmina Ziekenhuis
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: Scedosporium, Pseudallescheria, Pseudallescheria boydii, antifungal susceptibility, minimum inhibitory concentration, voriconazole, posaconazole, isavuconazole, itraconazole, micafungin, anidulafungin, caspofungin, amphotericin B, Scedosporium aurantiacum, Scedosporium prolificans, species-specific susceptibility, clinical and environmental isolates, antifungal resistance
Open Access status: bronze
Funders: Pfizer, Gilead Sciences, Astellas Pharma
OpenAlex ID: W2151043417
